NL-OMON38868已完成2 期
Pilot study: The use of PET-MRI in the follow-up of RFA treated colorectal liver metastases - PET-MRI after RFA
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Histological or cytological documentation of primary colorectal tumor
- •Radiological or histological prove of one or more CRLM or radiological prove of a LSR after previous RFA/MWA treatment for CRLM
- •CRLM or LSR treated with RFA/MWA or RFA/MWA in combination with resection
- •Follow-up imaging performed in VUmc medical centre
- •Age ³ 18 years
- •Life expectancy of at least 1 year
- •eGFR > 60 or hydration according to protocol before scanning
排除标准
- •Cirrosis or steatosis
- •Chemotherapy * 6 weeks before scanning (during the entire study)
- •Pregnant or breast-feeding subjects
- •Allergy to contrast media
- •Patients developing recurrent intrahepatic disease that require resection of the ablated lesion
- •eGFR < 60, unless hydration according to protocol is possible
- •General exclusion criteria to undergo MRI
研究者
相似试验
尚未招募
不适用
Pilot study: the use of PET-MRI in work-up of breast cancer patients.breastcancer10006291NL-OMON41083Radiologie10
招募中
不适用
Utility of PET-MRI in Surveillance of Paediatric Brain TumoursBrain Tumor, PediatricNCT05553899Sheffield Children's NHS Foundation Trust5
招募中
1 期
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active SurveillanceProstate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8NCT05852041Northwestern University40
已完成
不适用
PET/MRI and PET/CT in Diagnosing Younger Patients With CancerChildhood CancerNCT02287636Case Comprehensive Cancer Center13
进行中（未招募）
1 期
Phase II trial: uPAR PET/CT and FDG PET/MRI for determining lymph node metastases in patients with bladder cancerrinary bladder cancerMedDRA version: 19.0Level: LLTClassification code 10005004Term: Bladder cancer NOSSystem Organ Class: 100000004864EUCTR2016-001026-33-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET40